Anika Therapeutics made its interim CEO and president Cheryl Blanchard, PhD, permanent April 26, the company announced.
What you should know:
1. Dr. Blanchard served in the interim appointments since February 2020. She's been on Anika's board since August 2018.
2. She brings more than 25 years of executive experience to the role.
3. Before joining Anika, Dr. Blanchard served as the president and CEO of Microchips Biotech from 2014 until it sold in November 2019. She previously worked at Zimmer and Southwest Research Institute.